Christopher Hwang
Chief Tech/Sci/R&D Officer en TRANSCENTA HOLDING LIMITED .
Perfil
Christopher Hwang is currently the Chief Technology Officer & Executive VP at Transcenta Holding Ltd.
Prior to this, he worked at Genzyme Corp.
and Sanofi as a Senior Director from 1992 to 2016.
He received his undergraduate degree from Massachusetts Institute of Technology in 1985 and his doctorate degree from the same institution in 1992.
Cargos activos de Christopher Hwang
Empresas | Cargo | Inicio |
---|---|---|
TRANSCENTA HOLDING LIMITED | Chief Tech/Sci/R&D Officer | 01/02/2019 |
Antiguos cargos conocidos de Christopher Hwang.
Empresas | Cargo | Fin |
---|---|---|
SANOFI | Director/Board Member | 01/09/2016 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director/Board Member | 01/02/2016 |
Formación de Christopher Hwang.
Massachusetts Institute of Technology | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
SANOFI | Commercial Services |
TRANSCENTA HOLDING LIMITED | Health Technology |
Empresas privadas | 1 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Hwang